Surprising Findings Dot Day 2 of the Keystone Long-COVID Conference
We continue to take a deep dive into the “Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment” first-ever international conference on long COVID. Long-COVID research was always going to be a bit messy. Take a look at the...
Triple Coagulation Therapy Scores in Long COVID: Implications for ME/CFS, FM and POTS
Anticoagulant and anti-platelet therapy reduces symptoms significantly in long COVID. The implications for chronic fatigue syndrome (ME/CFS), fibromyalgia and POTS are discussed.
ME/CFS Muscle Study Results in Drug Company Startup
High sodium muscle findings in chronic fatigue syndrome (ME/CFS) have resulted in a startup company being formed to bring a drug to market.
Ischemia-Reperfusion Hypothesis Opens New Treatment Options for Long COVID, Fibromyalgia and ME/CFS
A focus on blood clots and impaired blood flows in long COVID is opening new treatment options for chronic fatigue syndrome and fibromyalgia as well.
Oxygen Short? Microcirculatory Problems Could Explain Long COVID (and ME/CFS)
New MRI technique reveals the oxygen from the lungs is having trouble getting through to the small blood vessels in long COVID. It could explain shortness of breath and exercise problems in long COVID and possibly ME/CFS. The Breathing-Oxygen series continues on...StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
